相关实验视频

Updated: Jan 8, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

激酶域二分化在EGFR激活中的作用

Zaritza O Petrova¹, Long Han¹, Yuko Tsutsui¹

¹Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA; Yale Cancer Biology Institute, Yale University West Campus, West Haven, CT 06516, USA.

Structure (London, England : 1993)

|December 20, 2025

概括

表皮生长因子受体 (EGFR) 的激活依赖于其氨酸激酶域 (TKD) 的短暂非对称二元. 这种短暂的二分化显著增加了激酶活性,这表明它.

科学领域:

生物化学生物化学
分子生物学分子生物学
结构生物学结构生物学

背景情况:

皮表皮生长因子受体 (EGFR) 是一种受体氨酸激酶 (RTK),由联体诱导的二分化激活.
结构上了解EGFR的细胞外区域二分化,但其细胞内氨酸激酶域 (TKD) 激活机制仍然不太清楚.
以前的研究表明,TKD在不对称二元体中的全激活,但这在冷电子显微镜 (cryo-EM) 研究中并未始终观察到.

研究的目的:

调查表皮生长因子受体 (EGFR) 中不对称的氨酸激酶域 (TKD) 模态的短暂性质.
阐明TKD二元化在EGFR激活和信号传递中的作用.
为了可视化和稳定暂时不对称的EGFR TKD二度体.

主要方法:

设计了一个不对称的EGFR的TKD二元体.
研究了一种TKD重复的肺癌EGFR变体.
使用冷电子显微镜 (cryo-EM) 来稳定和可视化EGFR TKD二次体.

主要成果:

证明EGFR的不对称TKD二元是短暂的,这解释了它在一些冷EM研究中缺席的原因.
表明TKD二分化会使EGFR激酶活性增加几百倍.
通过使用冷EM成功稳定和可视化高分辨率的离散不对称EGFR TKD模度.

结论:

EGFR中的致癌突变主要通过促进TKD二元化来激活受体.
由于EGFR TKD二分体的短暂性质,可能会使EGFR信号通路产生偏差.
了解EGFR TKD二元化提供了对RTK激活和潜在治疗策略的见解.

关键词:

癌症癌症癌症癌症癌症分化二元化是指二元化的过程.皮肤上生长因子受体.增长因子信号传递.瘤原性突变是一种致癌性突变.蛋白质构成的结构.接收器氨酸激酶的受体

更多相关视频

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Assaying Protein Kinase Activity with Radiolabeled ATP

Assaying Protein Kinase Activity with Radiolabeled ATP

Published on: May 26, 2017

相关概念视频

Receptor Tyrosine Kinases

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...

Amplifying Signals via Enzymatic Cascade

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...

Enzyme-linked Receptors

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...

MAPK Signaling Cascades

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...